Insitro nabs $400m in Series C financing led by CPPIB

Insitro, a machine learning-driven drug discovery and development company, has raised $400 million in Series C financing.

Insitro, a machine learning-driven drug discovery and development company, has raised $400 million in Series C financing. Canada Pension Plan Investment Board led the round with participation from other investors that included Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., Casdin Capital, funds and accounts managed by BlackRock, ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures, HOF Capital and Alexandria Venture Investments.

Source: Press Release